Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEAP2 in Overweight and Obesity
NCT07897383Phase 2Not yet recruiting
- Sponsor
- Gentofte Hospital
- Start
- Nov 2026
- Primary completion
- Aug 2027
01
Overview
A Phase 2 trial of liver-expressed antimicrobial peptide 2 in obesity, sponsored by Gentofte Hospital. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
liver-expressed antimicrobial peptide 2
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07897383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07897383.